Cytophage Technologies Ltd. (TSXV:CYTO)

Market Cap	2.71M -74.9%
Revenue (ttm)	n/a
Net Income	-4.57M
EPS	-0.08
Shares Out	67.69M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,000
Average Volume	73,886
Open	0.0400
Previous Close	0.0400
Day's Range	0.0250 - 0.0400
52-Week Range	0.0300 - 0.3950
Beta	0.11
RSI	38.84
Earnings Date	May 7, 2026

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Steven Theriault
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: CYTO